About Us

From Discovery to IVD production: We harnessing the power of multiplex technology on Luminex (TM) and other multi-omics technologies and we offer novel products and services for biomarker discovery, companion diagnostics, serology, patient stratification, and compound evaluation. Our GMP, ISO13485, and ISO9001 compliant quality management system translates your discovery idea to an IVD  product.

 

The company ProtATonce (now Protavio) was founded end of 2011 in Athens, Greece and expanded in UK in 2016. The advisory board is Doug Lauffenburger, Ford Professor of Biological Engineering, Chemical Engineering, and Biology at MIT and Peter Sorger, Otto Krayer Professor of Systems Pharmacology, Department of Systems Biology at Harvard Medical School. 

​

Today Protavio operates in both Greece and UK and offers smart, innovative products and services on regular & multiplex assays with state of the art facilities.